title: The RESPECT Trial: what will the FDA do?
authors.affiliation: zhijazi@rush.edu
authors.forename: Ziyad M
authors.initials: ZM
authors.lastname: Hijazi
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use*; D019468:Disease Management; D054092:Foramen Ovale, Patent / Q000628:therapy*; D006801:Humans; D015994:Incidence; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D055502:Secondary Prevention; D055989:Septal Occluder Device; D020521:Stroke / Q000453:epidemiology / Q000517:prevention & control*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors